Dr Rowan Miller

Dr Rowan Miller is a highly regarded consultant medical oncologist specialising in gynae-oncology and early phase clinical trials at University College London (UCL) and St Bartholomew’s Hospitals. Her expertise lies in the management of gynecological cancers and advancing cancer research through innovative trials, and she specialises in gynaecological cancer including ovarian/fallopian tube and endometrial cancers, and treatments including chemotherapy, targeted therapy, PARP inhibitors, and immunotherapy. 

Dr Miller successfully completed her undergraduate training at the University of Oxford, obtaining an MA in physiology in 2000. She would then go on to undertake clinical training at Guy’s and St Thomas’ Hospitals in London before achieving an MBBS at the University of London in 2004. Notably, Dr Miller was awarded a Cancer Research UK Fellowship and obtained her PhD from the Institute of Cancer Research. She also impressively completed a fellowship at the Dana Farber Cancer Institute, Harvard University.

What makes Dr Miller stand out is that she focuses on novel therapies for gynaecological cancer, utilising genomics and biomarkers to guide therapy, particularly in early-phase clinical trials. Dr Miller is actively engaged in several clinical trials and leads the ESMO Translational Research and Precision Medicine Working Group, playing a key role in their consensus recommendation paper on HRD testing in ovarian cancer.